AstraZeneca CEO Steps Down as Earnings Fall

David Brennan, CEO of AstraZeneca, is leaving his position following a dramatic drop in the company's performance. Investors have recently become discontent with the performance of the company. Earnings dropped 19 percent last quarter likely because some of their main products have lost patent protection. Some of the company's drugs that are losing patent protection are Seroquel, Nexium and Crestor. Proton Pump Inhibitors (PPIs) from various companies are losing patent protection, not just AstraZeneca.

PPIs are drugs that reduce acid in the stomach for those suffering from conditions such as ulcers and acid reflux disease. Some of these are prescribed while some are available over the counter. If you were injured by a PPI then you may have a claim against a company like AstraZeneca with the help of a pharmaceutical injury lawyer at our firm. Arnold & Itkin is committed to helping victims of dangerous drugs get compensated, so contact a dangerous drug lawyer from the firm today about your case.